Factors that Determine Genital Herpes Treatment
There’s no cure for herpes. But there are genital herpes treatment available to prevent further infections. Using genital herpes treatment over other available treatment depends on many factors, which you need to discuss with medical professionals.
Having herpes eruptions in the past is an important factor gives you an idea what genital herpes treatment to use. The initial herpes outbreak is often the worst. A persistent herpes outbreak is less painful compared to the initial episode, and there’s a reduced duration of outbreak.
Another determining factor for genital herpes treatment is the frequency of outbreaks. Healthcare providers recommend suppressive therapy for those experiencing over six outbreaks every year. Here, a sufferer takes daily medication to reduce the incidence of outbreaks.
Outbreak frequency decreases over time in many people. Thus, you should discuss with your healthcare provider occasionally. Discuss the benefits as well as risks of stopping everyday medications.
If you’re suffering from herpes and are active sexually, you’ll need some special consideration. Genital herpes treatment, which prevents the transmission of virus to known negative people is recommended. Many studies reveal that having therapy can reduce the risk of spreading the virus.
Those with genital herpes and weakened immune system as a result of leukemia, HIV/AIDS, and other conditions have higher risks of more severe infections. Where as people who exhibit herpes symptoms but with healthy immune system can lower your risks of infections.
Herpes simplex viruses (HSV) in persons with a weak immune system usually resists genital herpes treatment previously developed. Additionally, they’re also harder to treat. You may need high-dose herpes medications.
Genital herpes treatment can pose a challenge to a pregnant woman since herpes outbreaks during the last phase of pregnancy can transmit HSV to her baby. A pregnant woman can safely take particular antiviral genital treatment, but researchers have yet to test the safety of other drugs.